UPM Raflatac is expanding its range of labeling solutions to support pharmaceutical companies in improving patient safety through secure and tamper-evident packaging. These solutions offer an easy route to achieving full compliance with the EU Falsified Medicines Directive on packaging for prescription drugs and high-risk, over-the-counter medicines. With tamper-evident labeling patients can be sure that …
Continue reading “UPM Raflatac fights counterfeit drugs with new security label solutions”
